Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (892)	1/15/1999 5:48:00 PM
From: jopawa	Respond to of 2539

Down 4 in after market. AFTER THE BELL-Some gains but Monsanto, banks dip By Jennifer Westhoven NEW YORK, Jan 15 (Reuters) - Several stocks moved higher in after-hours trading including the market's latest debutante, Marketwatch.com (Nasdaq:MKTW - news), but banking shares and Monsanto Co. (NYSE:MTC - news) slipped slightly. Traders said after hours trading in U.S. stocks was quiet on Friday as U.S. investors headed home amid foul weather in New York and ahead of a three-day weekend. U.S. stock markets will be closed for Martin Luther King Jr. holiday. Shares of Walt Disney Co. (NYSE:DIS - news) moved slightly lower in third-market trading after its ABC broadcasting unit said it finally hit a deal with technical staff union workers, ending a 10-week lockout. Disney shares had closed down just slightly, 1/16 to 36, on the New York Stock Exchange at 1600 EST/2100 GMT. The news was announced just two minutes before the closing bell. Disney shares slipped slightly in the next 26 minutes of trading, with the stock closing down 5/16 at 35-3/4 on the Pacific Stock Exchange. There were no Disney trades reported on Instinet. Shares of Monsanto fell in heavy trading, Instinet traders said. The life sciences firm said just before the close that its Searle pharmaceutical unit abandoned two studies of anti-clotting drugs after the drugs did not turn up significant evidence they could cut the risk of repeated heart attacks. Monsanto was at 38-5/8 in after-hours trading, well off its close at 42 a share. Another drug stock that develops products to treat cardiovascular diseases, Centocor Inc (Nasdaq:CNTO - news), inched higher. The stock moved up to 41, an Instinet trader said, above its Nasdaq close at 40-3/8.